Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
In stark reversal, FDA to reconsider removal of Eli Lilly weight loss drug from shortage list
The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide, from its shortage list.
US FDA to reconsider decision barring compounded versions of Lilly weight loss drug
The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders from selling their own versions of Eli Lilly's blockbuster weight loss and diabetes drugs.
Knockoff weight loss drug sellers are fighting back against Eli Lilly and the FDA
Eli Lilly (LLY) is calling on companies that have been selling off-brand versions of its popular diabetes and weight-loss drugs during widespread shortages to halt production now that supplies are stabilizing.
As Eli Lilly, compounders battle over weight loss drugs, patients are caught in the middle
There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.
4029tv
6h
The end of a shortage of popular weight-loss drugs may mean many people lose access to them
The drug uses the active ingredient
tirzepatide
and was approved by the FDA in May 2022 for type 2 diabetes; although ...
2d
A Major GLP-1 Drug Shortage Is Over. Some Patients Aren’t Celebrating
Mounjaro and Zepbound are now out of shortage. This should be good news—but because so many patients are taking compounded ...
devdiscourse
2h
FDA Reconsiders Decision on Compounded Diabetes Drugs Amid Legal Pressure
The FDA has agreed to revisit its decision to prevent compounders from selling versions of Eli Lilly's diabetes and weight ...
2d
Drug makers can’t make knockoff weight-loss drugs anymore—and they’re mad
With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...
1d
The Crackdown on Compounded GLP-1 Meds Has Begun
Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” ...
The Hill
2h
Rivals fight for right to sell weight loss drugs
Federal regulators shook up a rapidly growing pharmaceutical marketplace when they announced that
tirzepatide
, the active ingredient in Eli Lilly’s Mounjaro and Zepbound, was no longer in shortage ...
Verywell Health on MSN
1d
Zepbound (Tirzepatide) vs. Wegovy (Semaglutide): How Do They Compare?
These drugs work similarly but differ in dosage and specific indications (uses). Research suggests that tirzepatide is more ...
Medpage Today on MSN
3d
Tirzepatide Shortage Resolved; Compounder Sues FDA; Menopause Mistaken as Dementia
All doses of the diabetes and weight management injectable tirzepatide (Mounjaro, Zepbound) were taken off the FDA's shortage ...
1d
Why Ozempic, Zepbound, and other weight-loss drug dupes carry risks
Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.
2minutemedicine.com
1d
Tirzepatide reduces obstructive sleep apnea symptoms and associated risks
In this randomized controlled trial, in patients with both moderate-severe obstructive sleep apnea (OSA) and obesity, it was ...
2d
Lexaria's GLP-1 Human Pilot Study #3 Begins Dosing
DehydraTECH-processed tirzepatide from Zepbound® is being tested in an oral dose format KELOWNA, BC / ACCESSWIRE / October 9, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Eli Lilly
Zepbound
Mounjaro
Ozempic
Food and Drug Administration
Feedback